An unknwon buyer acquired 60.66% stake in JW Life Science Corporation from JW Holdings Corporation (KOSE:A096760) for KRW 91 billion on June 14, 2013. JW Holdings sold 3.66 million shares in the transaction. After completion, JW Holdings holds 39.34% stake in JW Life Science. JW Life Science reported sales of KRW 89.09 billion, net income of KRW 3.17 billion, total assets of KRW 153.73 billion and shareholders' equity of KRW 68.34 billion for the year ending December 31, 2012. The Board of Directors of JW Holdings resolved to undertake the transaction on June 14, 2013.


An unknwon buyer completed the acquisition of 60.66% stake in JW Life Science Corporation from JW Holdings Corporation (KOSE:A096760) on June 14, 2013.